DS STAGE II MULTIPLE MYELOMA
Clinical trials for DS STAGE II MULTIPLE MYELOMA explained in plain language.
Never miss a new study
Get alerted when new DS STAGE II MULTIPLE MYELOMA trials appear
Sign up with your email to follow new studies for DS STAGE II MULTIPLE MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy shows promise in myeloma battle
Disease control OngoingThis study tested two different doses of dexamethasone (a chemotherapy drug) combined with lenalidomide (an immune-boosting drug) in 452 people newly diagnosed with multiple myeloma. The goal was to see which dose worked better at shrinking tumors. If the first combination didn't…
Matched conditions: DS STAGE II MULTIPLE MYELOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
Promising drug may delay myeloma return after transplant
Disease control OngoingThis study tested whether taking lenalidomide (a drug that helps the immune system fight cancer) after a stem cell transplant could keep multiple myeloma from coming back longer than taking a placebo. About 460 people with active multiple myeloma took part. The goal was to see if…
Matched conditions: DS STAGE II MULTIPLE MYELOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC